{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:40:42Z","timestamp":1790836842447,"version":"4.1.0"},"reference-count":104,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T00:00:00Z","timestamp":1686182400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathogens"],"abstract":"<jats:p>Chronic viral hepatitis infections, caused by the hepatitis B or C virus, are a major global health problem causing an estimated one million deaths each year. Immunological studies have classically focused on T cells, while B cells have largely been neglected. Emerging evidence, however, highlights a role for B cells in the immunopathogenesis of chronic hepatitis B and C infections. B cell responses appear to be altered across different clinical phases of chronic HBV infection and across stages of disease in chronic HCV infection. These B cell responses show signs of a more activated state with a simultaneous enrichment of phenotypically exhausted atypical memory B cells. Despite the fact that studies show an activating B cell signature in chronic viral hepatitis infection, antibody responses to HBsAg remain impaired in chronic HBV infection, and glycoprotein E2-specific neutralizing antibody responses remain delayed in the acute phase of HCV infection. At the same time, studies have reported that a subset of HBV- and HCV-specific B cells exhibit an exhausted phenotype. This may, at least in part, explain why antibody responses in chronic HBV and HCV patients are suboptimal. Here, we summarize recent findings and discuss upcoming research questions while looking forward to how new single-cell technologies could provide novel insights into the role of B cells in chronic viral hepatitis infections.<\/jats:p>","DOI":"10.3390\/pathogens12060815","type":"journal-article","created":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T02:58:32Z","timestamp":1686193112000},"page":"815","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Recent Insights into the Role of B Cells in Chronic Hepatitis B and C Infections"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5210-8943","authenticated-orcid":false,"given":"Zgjim","family":"Osmani","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8607-1616","authenticated-orcid":false,"given":"Andre","family":"Boonstra","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,6,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cld.2009.11.009","article-title":"Epidemiology of hepatitis B and C viruses: A global overview","volume":"14","author":"Te","year":"2010","journal-title":"Clin. Liver Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S2468-1253(22)00386-7","article-title":"Global reporting of progress towards elimination of hepatitis B and hepatitis C","volume":"8","author":"Cui","year":"2023","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1002\/hep.22881","article-title":"Hepatitis B: The virus and disease","volume":"49","author":"Liang","year":"2009","journal-title":"Hepatology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nri3169","article-title":"Living in the liver: Hepatic infections","volume":"12","author":"Protzer","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrmicro1645","article-title":"Replication of hepatitis C virus","volume":"5","author":"Moradpour","year":"2007","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"6266","DOI":"10.1016\/j.vaccine.2008.09.056","article-title":"The global impact of vaccination against hepatitis B: A historical overview","volume":"26","author":"Zanetti","year":"2008","journal-title":"Vaccine"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1001\/jama.1996.03540110060032","article-title":"Seroepidemiology of hepatitis B virus infection in children: Ten years of mass vaccination in Taiwan","volume":"276","author":"Chen","year":"1996","journal-title":"JAMA"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Esser, K., Cheng, X., Wettengel, J.M., Lucifora, J., Hansen-Palmus, L., Austen, K., Suarez, A.A.R., Heintz, S., Testoni, B., and Nebioglu, F. (2023). Hepatitis B Virus Targets Lipid Transport Pathways to Infect Hepatocytes. Cell. Mol. Gastroenterol. Hepatol., in press.","DOI":"10.1016\/j.jcmgh.2023.03.011"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Herrscher, C., Roingeard, P., and Blanchard, E. (2020). Hepatitis B Virus Entry into Cells. Cells, 9.","DOI":"10.3390\/cells9061486"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJMra031087","article-title":"Hepatitis B virus infection\u2014Natural history and clinical consequences","volume":"350","author":"Ganem","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3748\/wjg.v13.i1.48","article-title":"Hepatitis B virus replication","volume":"13","author":"Beck","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"775098","DOI":"10.3389\/fimmu.2021.775098","article-title":"A Role for B Cells to Transmit Hepatitis C Virus Infection","volume":"12","author":"Desombere","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1038\/onc.2015.364","article-title":"Hepatitis C virus upregulates B-cell receptor signaling: A novel mechanism for HCV-associated B-cell lymphoproliferative disorders","volume":"35","author":"Dai","year":"2016","journal-title":"Oncogene"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1089\/jir.2009.0047","article-title":"Possible recruitment of peripheral blood CXCR3+ CD27+ CD19+ B cells to the liver of chronic hepatitis C patients","volume":"30","author":"Mizuochi","year":"2010","journal-title":"J. Interferon Cytokine Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/s41586-021-03913-5","article-title":"Structural insights into hepatitis C virus receptor binding and entry","volume":"598","author":"Kumar","year":"2021","journal-title":"Nature"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/1756283X09353353","article-title":"Hepatitis C virus replication and potential targets for direct-acting agents","volume":"3","author":"Davis","year":"2010","journal-title":"Therap. Adv. Gastroenterol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/S0140-6736(14)60220-8","article-title":"Hepatitis B virus infection","volume":"384","author":"Chan","year":"2014","journal-title":"Lancet"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.jhep.2014.07.012","article-title":"Natural history of hepatitis C","volume":"61","author":"Westbrook","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver (2017). EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J. Hepatol., 67, 370\u2013398.","DOI":"10.1016\/j.jhep.2017.03.021"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1075916","DOI":"10.3389\/fimmu.2022.1075916","article-title":"Hepatitis B functional cure and immune response","volume":"13","author":"Zheng","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nri.2016.69","article-title":"Immune responses and immunopathology in acute and chronic viral hepatitis","volume":"16","author":"Shin","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s40121-018-0210-5","article-title":"HIV, HCV and HBV: A Review of Parallels and Differences","volume":"7","author":"Leoni","year":"2018","journal-title":"Infect. Dis. Ther."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Tu, T., Zhang, H., and Urban, S. (2021). Hepatitis B Virus DNA Integration: In Vitro Models for Investigating Viral Pathogenesis and Persistence. Viruses, 13.","DOI":"10.3390\/v13020180"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2217\/fvl.13.11","article-title":"Viral hepatitis in resource-limited countries and access to antiviral therapies: Current and future challenges","volume":"8","author":"Lemoine","year":"2013","journal-title":"Future Virol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S2468-1253(22)00201-1","article-title":"Prevalence of occult hepatitis B virus infection in adults: A systematic review and meta-analysis","volume":"7","author":"Im","year":"2022","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/j.jhep.2014.09.009","article-title":"A prophylactic hepatitis C virus vaccine: A distant peak still worth climbing","volume":"61","author":"Baumert","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/cei.13614","article-title":"Therapeutic vaccination for treatment of chronic hepatitis B","volume":"205","author":"Cargill","year":"2021","journal-title":"Clin. Exp. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.antiviral.2012.07.006","article-title":"Therapeutic vaccination against chronic hepatitis C virus infection","volume":"96","author":"Ip","year":"2012","journal-title":"Antivir. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e1232","DOI":"10.1002\/cti2.1232","article-title":"Designing the next-generation therapeutic vaccines to cure chronic hepatitis B: Focus on antigen presentation, vaccine properties and effect measures","volume":"10","author":"Jansen","year":"2021","journal-title":"Clin. Transl. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.jhep.2010.09.040","article-title":"Progress in the development of preventive and therapeutic vaccines for hepatitis C virus","volume":"54","author":"Torresi","year":"2011","journal-title":"J. Hepatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1056\/NEJMra2211764","article-title":"New Approaches to Chronic Hepatitis B","volume":"388","author":"Dusheiko","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/hep.32470","article-title":"A pan-genotype hepatitis C virus viral vector vaccine generates T cells and neutralizing antibodies in mice","volume":"76","author":"Donnison","year":"2022","journal-title":"Hepatology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jhep.2019.11.011","article-title":"B cell immunodominance in primary hepatitis C virus infection","volume":"72","author":"Brasher","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jhep.2022.02.020","article-title":"Immunological biomarker discovery in cure regimens for chronic hepatitis B virus infection","volume":"77","author":"Gehring","year":"2022","journal-title":"J. Hepatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S2468-1253(19)30119-0","article-title":"A global scientific strategy to cure hepatitis B","volume":"4","author":"Revill","year":"2019","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.bpg.2017.05.003","article-title":"Hepatitis B virus infection and the immune response: The big questions","volume":"31","author":"Boeijen","year":"2017","journal-title":"Best. Pract. Res. Clin. Gastroenterol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1038\/s41598-020-59406-4","article-title":"Moderate Risk of Hepatitis B Virus Reactivation in HBsAg(\u2212)\/HBcAb(+) Carriers Receiving Rituximab for Rheumatoid Arthritis","volume":"10","author":"Kuo","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1111\/1756-185X.13582","article-title":"Reactivation of hepatitis B virus infection following rituximab treatment in HBsAg-negative, HBcAb-positive rheumatoid arthritis patients: A long-term, real-world observation","volume":"22","author":"Chen","year":"2019","journal-title":"Int. J. Rheum. Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1182\/blood-2018-04-848044","article-title":"Risk of HBV reactivation in patients with B-cell lymphomas receiving obinutuzumab or rituximab immunochemotherapy","volume":"133","author":"Kusumoto","year":"2019","journal-title":"Blood"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1200\/JCO.2008.18.0182","article-title":"Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab","volume":"27","author":"Yeo","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"15629","DOI":"10.1038\/s41598-018-34111-5","article-title":"Effects of rituximab dose on hepatitis B reactivation in patients with resolved infection undergoing immunologic incompatible kidney transplantation","volume":"8","author":"Lee","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1053\/j.gastro.2017.02.009","article-title":"Hepatitis B Reactivation Associated With Immune Suppressive and Biological Modifier Therapies: Current Concepts, Management Strategies, and Future Directions","volume":"152","author":"Loomba","year":"2017","journal-title":"Gastroenterology"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S0168-8278(03)00075-8","article-title":"Expansion of innate CD5pos B cells expressing high levels of CD81 in hepatitis C virus infected liver","volume":"38","author":"Curry","year":"2003","journal-title":"J. Hepatol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/hep.27805","article-title":"Re-evaluation of hepatitis B virus clinical phases by systems biology identifies unappreciated roles for the innate immune response and B cells","volume":"62","author":"Vanwolleghem","year":"2015","journal-title":"Hepatology"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Hou, J., Brouwer, W.P., Kreefft, K., Gama, L., Price, S.L., Janssen, H.L.A., French, P.J., Vanwolleghem, T., and Boonstra, A. (2017). Unique intrahepatic transcriptomics profiles discriminate the clinical phases of a chronic HBV infection. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0179920"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jhep.2022.02.016","article-title":"Multi-parametric analysis of human livers reveals variation in intrahepatic inflammation across phases of chronic hepatitis B infection","volume":"77","author":"Montanari","year":"2022","journal-title":"J. Hepatol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"100388","DOI":"10.1016\/j.jhepr.2021.100388","article-title":"Characterization of the liver immune microenvironment in liver biopsies from patients with chronic HBV infection","volume":"4","author":"Ramirez","year":"2022","journal-title":"JHEP Rep."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Rosenberg, B.R., Depla, M., Freije, C.A., Gaucher, D., Mazouz, S., Boisvert, M., B\u00e9dard, N., Bruneau, J., Rice, C.M., and Shoukry, N.H. (2018). Longitudinal transcriptomic characterization of the immune response to acute hepatitis C virus infection in patients with spontaneous viral clearance. PLoS Pathog., 14.","DOI":"10.1371\/journal.ppat.1007290"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"816","DOI":"10.15252\/emmm.201607006","article-title":"Transcriptional response to hepatitis C virus infection and interferon-alpha treatment in the human liver","volume":"9","author":"Boldanova","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"104283","DOI":"10.1016\/j.cellimm.2021.104283","article-title":"Sorted B cell transcriptomes point towards actively regulated B cell responses during ongoing chronic hepatitis B infections","volume":"362","author":"Cuypers","year":"2021","journal-title":"Cell. Immunol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"105801","DOI":"10.1016\/j.isci.2022.105801","article-title":"Peripheral B cells from patients with hepatitis C virus-associated lymphoma exhibit clonal expansion and an anergic-like transcriptional profile","volume":"26","author":"Henning","year":"2023","journal-title":"iScience"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/cmi.2015.25","article-title":"Reversal of B-cell hyperactivation and functional impairment is associated with HBsAg seroconversion in chronic hepatitis B patients","volume":"12","author":"Xu","year":"2015","journal-title":"Cell. Mol. Immunol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.1172\/JCI121957","article-title":"PD-1 blockade partially recovers dysfunctional virus-specific B cells in chronic hepatitis B infection","volume":"128","author":"Salimzadeh","year":"2018","journal-title":"J. Clin. Investig."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jhep.2010.10.016","article-title":"Enhanced B-cell differentiation and reduced proliferative capacity in chronic hepatitis C and chronic hepatitis B virus infections","volume":"55","author":"Oliviero","year":"2011","journal-title":"J. Hepatol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"18544","DOI":"10.1073\/pnas.0509402102","article-title":"Activation of na\u00efve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders","volume":"102","author":"Rosa","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Santer, D.M., Ma, M.M., Hockman, D., Landi, A., Tyrrell, D.L., and Houghton, M. (2013). Enhanced activation of memory, but not na\u00efve, B cells in chronic hepatitis C virus-infected patients with cryoglobulinemia and advanced liver fibrosis. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0068308"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/jvh.12336","article-title":"Skewed B cells in chronic hepatitis C virus infection maintain their ability to respond to virus-induced activation","volume":"22","author":"Oliviero","year":"2015","journal-title":"J. Viral Hepat."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.4049\/jimmunol.1000879","article-title":"Peripheral blood B cell subset skewing is associated with altered cell cycling and intrinsic resistance to apoptosis and reflects a state of immune activation in chronic hepatitis C virus infection","volume":"185","author":"Sugalski","year":"2010","journal-title":"J. Immunol."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"He, Y., Guo, Y., Zhou, Y., Zhang, Y., Fan, C., Ji, G., Wang, Y., Ma, Z., Lian, J., and Hao, C. (2014). CD100 up-regulation induced by interferon-\u03b1 on B cells is related to hepatitis C virus infection. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0113338"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jhep.2020.01.024","article-title":"Hepatitis B core-specific memory B cell responses associate with clinical parameters in patients with chronic HBV","volume":"73","author":"Vanwolleghem","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1038\/s41467-022-33035-z","article-title":"Serum neutralization activity declines but memory B cells persist after cure of chronic hepatitis C","volume":"13","author":"Nishio","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jhep.2019.07.015","article-title":"Comparative characterization of B cells specific for HBV nucleocapsid and envelope proteins in patients with chronic hepatitis B","volume":"72","author":"Salimzadeh","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1172\/JCI121960","article-title":"Circulating and intrahepatic antiviral B cells are defective in hepatitis B","volume":"128","author":"Burton","year":"2018","journal-title":"J. Clin. Investig."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Ogega, C.O., Skinner, N.E., Flyak, A.I., Clark, K.E., Board, N.L., Bjorkman, P.J., Crowe, J.E., Cox, A.L., Ray, S.C., and Bailey, J.R. (2022). B cell overexpression of FCRL5 and PD-1 is associated with low antibody titers in HCV infection. PLoS Pathog., 18.","DOI":"10.1371\/journal.ppat.1010179"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1056\/NEJM198308253090803","article-title":"Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome","volume":"309","author":"Lane","year":"1983","journal-title":"N. Engl. J. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nri2524","article-title":"B cells in HIV infection and disease","volume":"9","author":"Moir","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jhep.2014.09.024","article-title":"CD4+ CXCR5+ T cells in chronic HCV infection produce less IL-21, yet are efficient at supporting B cell responses","volume":"62","author":"Spaan","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0016-5085(93)90432-C","article-title":"Pathological diagnosis of chronic hepatitis C: A multicenter comparative study with chronic hepatitis B. The Hepatitis Interventional Therapy Group","volume":"104","author":"Lefkowitch","year":"1993","journal-title":"Gastroenterology"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.jhep.2017.12.008","article-title":"Anti-HBV response to toll-like receptor 7 agonist GS-9620 is associated with intrahepatic aggregates of T cells and B cells","volume":"68","author":"Li","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1111\/liv.15568","article-title":"Toll-like receptor 7 agonist, GS-986, is an immune-stimulant inducing follicular helper T cells and expanding HBs antigen-specific B cells in vitro","volume":"43","author":"Mori","year":"2023","journal-title":"Liver Int."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1002\/eji.201445389","article-title":"Evidence of B-cell follicles with germinal centers in chronic hepatitis C patients","volume":"45","year":"2015","journal-title":"Eur. J. Immunol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/hep.510300107","article-title":"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C","volume":"30","author":"Murakami","year":"1999","journal-title":"Hepatology"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.4049\/jimmunol.1600763","article-title":"Novel E2 Glycoprotein Tetramer Detects Hepatitis C Virus-Specific Memory B Cells","volume":"197","author":"Boisvert","year":"2016","journal-title":"J. Immunol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jim.2019.06.016","article-title":"A method for detecting hepatitis C envelope specific memory B cells from multiple genotypes using cocktail E2 tetramers","volume":"472","author":"Wu","year":"2019","journal-title":"J. Immunol. Methods"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.antiviral.2003.08.011","article-title":"The nucleocapsid of the hepatitis B virus: A remarkable immunogenic structure","volume":"60","author":"Vanlandschoot","year":"2003","journal-title":"Antiviral Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1126\/science.3491425","article-title":"The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen","volume":"234","author":"Milich","year":"1986","journal-title":"Science"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3389\/fimmu.2020.00849","article-title":"Pathogenetic Mechanisms of T Cell Dysfunction in Chronic HBV Infection and Related Therapeutic Approaches","volume":"11","author":"Fisicaro","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jhep.2020.04.013","article-title":"Hepatitis B surface antigen seroclearance: Immune mechanisms, clinical impact, importance for drug development","volume":"73","author":"Tout","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1053\/j.gastro.2012.07.014","article-title":"Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues","volume":"143","author":"Boni","year":"2012","journal-title":"Gastroenterology"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1053\/j.gastro.2020.04.019","article-title":"Effects of Hepatitis B Surface Antigen on Virus-Specific and Global T Cells in Patients with Chronic Hepatitis B Virus infection","volume":"159","author":"Gill","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1038\/s41598-020-58870-2","article-title":"Circulating serum HBsAg level is a biomarker for HBV-specific T and B cell responses in chronic hepatitis B patients","volume":"10","author":"Kim","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"15296","DOI":"10.1038\/s41598-018-33719-x","article-title":"HBV induces inhibitory FcRL receptor on B cells and dysregulates B cell-T follicular helper cell axis","volume":"8","author":"Poonia","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"6624","DOI":"10.4049\/jimmunol.178.10.6624","article-title":"A new population of cells lacking expression of CD27 represents a notable component of the B cell memory compartment in systemic lupus erythematosus","volume":"178","author":"Wei","year":"2007","journal-title":"J. Immunol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1084\/jem.20072683","article-title":"Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals","volume":"205","author":"Moir","year":"2008","journal-title":"J. Exp. Med."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.4049\/jimmunol.0901297","article-title":"Atypical memory B cells are greatly expanded in individuals living in a malaria-endemic area","volume":"183","author":"Weiss","year":"2009","journal-title":"J. Immunol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"108684","DOI":"10.1016\/j.celrep.2020.108684","article-title":"Atypical B cells are part of an alternative lineage of B cells that participates in responses to vaccination and infection in humans","volume":"34","author":"Sutton","year":"2021","journal-title":"Cell. Rep."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/jvh.12659","article-title":"Hepatitis C viraemia reversibly maintains subset of antigen-specific T-bet+ tissue-like memory B cells","volume":"24","author":"Chang","year":"2017","journal-title":"J. Viral Hepat."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cellimm.2017.04.012","article-title":"T-bet-expressing B cells during HIV and HCV infections","volume":"321","author":"Knox","year":"2017","journal-title":"Cell. Immunol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"5425","DOI":"10.1182\/blood-2010-10-312942","article-title":"Clonal B cells in patients with hepatitis C virus-associated mixed cryoglobulinemia contain an expanded anergic CD21low B-cell subset","volume":"117","author":"Charles","year":"2011","journal-title":"Blood"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/art.38222","article-title":"CD21(-\/low) marginal zone B cells highly express Fc receptor-like 5 protein and are killed by anti-Fc receptor-like 5 immunotoxins in hepatitis C virus-associated mixed cryoglobulinemia vasculitis","volume":"66","author":"Terrier","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.clim.2013.12.001","article-title":"Peripheral CD27-CD21-B-cells represent an exhausted lymphocyte population in hepatitis C cirrhosis","volume":"150","author":"Doi","year":"2014","journal-title":"Clin. Immunol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.immuni.2023.03.001","article-title":"A transcriptionally distinct subset of influenza-specific effector memory B cells predicts long-lived antibody responses to vaccination in humans","volume":"56","author":"Nellore","year":"2023","journal-title":"Immunity"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/s41590-020-00814-z","article-title":"Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19","volume":"21","author":"Woodruff","year":"2020","journal-title":"Nat. Immunol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.immuni.2020.03.020","article-title":"The Transcription Factor T-bet Resolves Memory B Cell Subsets with Distinct Tissue Distributions and Antibody Specificities in Mice and Humans","volume":"52","author":"Johnson","year":"2020","journal-title":"Immunity"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.immuni.2019.04.004","article-title":"T-bet Transcription Factor Promotes Antibody-Secreting Cell Differentiation by Limiting the Inflammatory Effects of IFN-\u03b3 on B Cells","volume":"50","author":"Stone","year":"2019","journal-title":"Immunity"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.immuni.2018.08.015","article-title":"Distinct Effector B Cells Induced by Unregulated Toll-like Receptor 7 Contribute to Pathogenic Responses in Systemic Lupus Erythematosus","volume":"49","author":"Jenks","year":"2018","journal-title":"Immunity"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.jhep.2014.06.035","article-title":"Innate and adaptive immune responses in HCV infections","volume":"61","author":"Heim","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jhep.2020.01.005","article-title":"Broadly neutralizing antibodies against hepatitis C virus: Location, location, location","volume":"72","author":"Skinner","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2019.06.029","article-title":"TLR9 signalling in HCV-associated atypical memory B cells triggers Th1 and rheumatoid factor autoantibody responses","volume":"71","author":"Comarmond","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Genshaft, A.S., Subudhi, S., Keo, A., Sanchez Vasquez, J.D., Concei\u00e7\u00e3o-Neto, N., Mahamed, D., Boeijen, L.L., Alatrakchi, N., Oetheimer, C., and Vilme, M. (2023). Single-cell RNA sequencing of liver fine-needle aspirates captures immune diversity in the blood and liver in chronic hepatitis B patients. Hepatology, epub ahead of print.","DOI":"10.1097\/HEP.0000000000000438"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1365-2893.2005.00626.x","article-title":"Flow cytometry of fine-needle-aspiration biopsies: A new method to monitor the intrahepatic immunological environment in chronic viral hepatitis","volume":"12","author":"Sprengers","year":"2005","journal-title":"J. Viral Hepat."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1136\/gutjnl-2018-317071","article-title":"Fine needle aspirates comprehensively sample intrahepatic immunity","volume":"68","author":"Gill","year":"2019","journal-title":"Gut"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.antiviral.2015.09.006","article-title":"Longitudinal analysis of peripheral and intrahepatic NK cells in chronic HCV patients during antiviral therapy","volume":"123","author":"Spaan","year":"2015","journal-title":"Antivir. Res."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"5323","DOI":"10.1128\/JVI.02551-10","article-title":"Retention of CD4+ CD25+ FoxP3+ regulatory T cells in the liver after therapy-induced hepatitis C virus eradication in humans","volume":"85","author":"Claassen","year":"2011","journal-title":"J. Virol."}],"container-title":["Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-0817\/12\/6\/815\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:50:37Z","timestamp":1760125837000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-0817\/12\/6\/815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,8]]},"references-count":104,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["pathogens12060815"],"URL":"https:\/\/doi.org\/10.3390\/pathogens12060815","relation":{},"ISSN":["2076-0817"],"issn-type":[{"value":"2076-0817","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,8]]}}}